Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates
Induced pluripotent stem cells (iPSCs) can serve as a source of cardiomyocytes (CMs) to treat end-stage heart failure; however, transplantation of genetically dissimilar iPSCs even within species (allogeneic) can induce immune rejection. We hypothesized that this might be limited by matching the maj...
Main Authors: | Takuji Kawamura, Shigeru Miyagawa, Satsuki Fukushima, Akira Maeda, Noriyuki Kashiyama, Ai Kawamura, Kenji Miki, Keisuke Okita, Yoshinori Yoshida, Takashi Shiina, Kazumasa Ogasawara, Shuji Miyagawa, Koichi Toda, Hiroomi Okuyama, Yoshiki Sawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-03-01
|
Series: | Stem Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213671116000291 |
Similar Items
-
N-glycans: phenotypic homology and structural differences between myocardial cells and induced pluripotent stem cell-derived cardiomyocytes.
by: Takuji Kawamura, et al.
Published: (2014-01-01) -
Vasculogenically conditioned peripheral blood mononuclear cells inhibit mouse immune response to induced pluripotent stem cell-derived allogeneic cardiac grafts.
by: Noriyuki Kashiyama, et al.
Published: (2019-01-01) -
Development of PET Imaging to Visualize Activated Macrophages Accumulated in the Transplanted iPSc-Derived Cardiac Myocytes of Allogeneic Origin for Detecting the Immune Rejection of Allogeneic Cell Transplants in Mice.
by: Noriyuki Kashiyama, et al.
Published: (2016-01-01) -
MHC-identical and transgenic cynomolgus macaques for preclinical studies
by: Hirohito Ishigaki, et al.
Published: (2018-11-01) -
Enhanced Pulmonary Vascular and Alveolar Development via Prenatal Administration of a Slow-Release Synthetic Prostacyclin Agonist in Rat Fetal Lung Hypoplasia.
by: Satoshi Umeda, et al.
Published: (2016-01-01)